Beaumont seeking volunteers for prostate treatment study
Investigators at Beaumont Hospital, Royal Oak are seeking volunteers with prostate cancer for a research trial that uses state-of-the-art stereotactic radiosurgical techniques to reduce treatment from eight and a half weeks to two weeks.
"The standard for men with localized prostate cancer is 42-44 treatments over two months," says Daniel Krauss, M.D., principal investigator and radiation oncologist. "By shortening the length of the treatment course, we hope to reduce costs and make it more convenient for patients, without compromising the treatment quality or safety."
According to the National Cancer Institute, nearly 250,000 American men were diagnosed with prostate cancer in 2011. After skin cancer, prostate cancer is the most common cancer diagnosed nationally among men. The prostate is part of a man's reproductive system.
To be eligible for the study, individuals must:
- Have biopsy-proven prostate cancer
For more information regarding the study or eligibility, call 248-551-3576.
Beaumont's comprehensive cancer program combines the expertise of surgical, medical and radiation oncologists to offer cancer prevention counseling, diagnosis and treatment in hospital and community-based settings. The Beaumont Cancer Institute is one of only 47 Community Clinical Oncology Programs in the country designated by the National Cancer Institute to provide patients with access to leading-edge cancer clinical research trials. Beaumont is designated as a Blue Cross Center of Distinction for the Treatment of Rare and Complex Cancers.
# # #